Monetization Of State
Home >> partners >> Innoplexus
Enabling next-generation medicines and cures. We transform healthcare with AI and data. Innoplexus is an Expert in AI & Life Science and is Supported by Extensive IP, Top Talent, and Leading Tech Partners.
Innoplexus is a leading global AI-based company for drug discovery and development with over 300 employees and 150+ patent applications including 70+ grants in artificial intelligence, machine learning and blockchain technologies. Innoplexus’ solutions can generate real-time insights from hundreds of terabytes of structured and unstructured private and public data, thereby facilitating continuous, informed decision-making for its customer base at an unprecedented speed. Founded in 2015, Innoplexus AG is headquartered in Eschborn, Germany, with offices in Pune, India, as well as in Iselin, United States.
Data Scientists
Medical Experts
Software Engineers
Commercials
Role In DIISHA
Innoplexus will handle front-end services and negotiate with users to financially support DIISHA on an annuity model. They will povide approved statistics and reports for R&D in medical fields, leveraging their AI-powered platform and data captured by ASHA and FLHW.
Innoplexus will empower DIISHA by integrating diverse data sources to generate comprehensive clinical healthcare data and enhance patient outcomes.
Innoplexus will analyze real Indian rural healthcare data to provide valuable insights for improving and updating existing Indian healthcare guidelines, supporting DIISHA.
We have a track record of serving various industry stakeholders and demonstrating the potential for expertise-driven collaborations.
We provide tailored solutions for developing India-specific drugs and therapies, including research, clinical development, real-world data analytics, and biomarker discovery.
Our strategic partnership in the life science industry will help DIISHA forge collaborations with relevant stakeholders.
HOW WE WORK
collaboration-icon Deep Collaboration with Pharma and Biotech partners to resolve bottlnecks in iterative milestones
Patented AI Technology, Aggregates and Analyzes data
Robust Medical Validation and enterprise level security by Subject matter experts.
